The federal Controlled Substances Act and the state professional licensing statutes that govern veterinary and dental practice create a layered compliance environment that does not bend to the closing timeline of an M&A transaction. DEA registrations are issued to specific practitioners and entities at specific locations. They are not property that can be assigned in an asset purchase agreement. State veterinary board and dental board licenses follow a similar rule: they identify a licensee, and a change of ownership does not transfer them to the new operator. The buyer must obtain its own registrations and licenses, and the process takes time that must be built into the transaction structure before the letter of intent is signed.
The analysis that follows covers the twelve categories of regulatory and transactional issues that counsel must address in any veterinary or dental practice acquisition involving controlled substances. The framework applies across deal structures, though asset acquisitions and stock acquisitions create different default positions on several issues. Each section identifies the specific statutory provisions, processing timelines, and drafting approaches that determine whether a buyer can operate the practice on the day after closing.
DEA Form 224 Mechanics: Registration Is Individual, Not Transferable, and the Successor Registration Process
The Drug Enforcement Administration issues controlled substance registrations under 21 U.S.C. Section 823, and the statutory framework makes clear that a registration authorizes a specific registrant at a specific registered location to handle controlled substances in the manner authorized by the registration's schedule. A registration issued to a selling veterinarian or dental practice entity does not extend to the buyer of that practice. There is no assignment box on the DEA Form 224 and no statutory mechanism for transferring an existing registration to a new owner. The buyer must submit its own Form 224 and obtain its own registration before it can lawfully order, dispense, administer, or prescribe controlled substances at the acquired location.
Form 224 is the application for a new DEA practitioner registration. It collects the applicant's identifying information, the proposed registered address, the business activity the registration will cover (practitioner, mid-level practitioner, or other designated categories), and the schedules of controlled substances the registrant intends to handle. For a veterinary practice, the application must identify the schedules used in clinical practice, which typically include Schedule II through Schedule V substances covering opioids, sedatives, and anesthetic agents. For a dental practice, the application covers the same range of substances used in pain management, sedation, and anxiety control.
The DEA's stated processing time for a new Form 224 application is approximately 30 days from receipt of a complete application, assuming the background investigation does not reveal issues requiring additional review. In practice, processing times vary by DEA regional division, by the complexity of the applicant's professional history, and by workload cycles that are difficult to predict in advance. Applications submitted with any deficiency, including missing state license information, incomplete business structure details, or discrepancies between the proposed registered address and the state license address on file, will be returned for correction and the processing clock will restart. Counsel should build a minimum 60-day buffer into the deal timeline and should communicate directly with the applicable DEA Diversion Field Office to confirm current processing times before the letter of intent is executed.
When the DEA approves the application, it issues a Certificate of Registration identifying the registrant, the registered location, the authorized schedules, and the registration expiration date. The certificate must be kept at the registered location and must be available for inspection by DEA officers. A separate registration is required for each location where controlled substances are stored, dispensed, or administered, which means a buyer acquiring a practice with multiple locations must submit a separate Form 224 for each location. The registered address on the Form 224 must match the address at which the buyer intends to maintain controlled substance records and storage, which must in turn comply with the DEA's storage security requirements for the schedules authorized.
State Controlled Substance Registration: Dual DEA and State Requirement, California BPC Section 11100
Federal DEA registration is a necessary condition for lawful controlled substance handling but is not sufficient in states that impose their own parallel controlled substance registration requirements. The majority of states require practitioners and practice entities to obtain a state-level controlled substance registration in addition to the federal DEA registration. The state registration is issued by the state pharmacy board, department of public health, or a designated drug enforcement division within the state, depending on the jurisdiction. It covers the same categories of controlled substance activity as the DEA registration but is administered under state law and carries its own application, fee, and renewal requirements.
California Business and Professions Code Section 11100 et seq. establishes the framework for California's controlled substances program, which requires a state-issued registration in addition to DEA registration for practitioners in California. The California Department of Justice, Bureau of Narcotic Enforcement administers this program and issues controlled substance registrations to practitioners who hold a valid DEA registration and a current California professional license. A buyer acquiring a California veterinary or dental practice must obtain both a new DEA registration and a new California controlled substance registration before handling controlled substances at the acquired location. The California registration application mirrors the DEA application in several respects but requires the applicant to identify their California professional license number and to certify compliance with California's controlled substance security, recordkeeping, and reporting requirements.
Texas maintains a separate controlled substance registration through the Texas Department of Public Safety, which issues a Texas Controlled Substances Registration to practitioners who hold a valid DEA registration and an active Texas professional license. Florida requires a separate controlled substance registration through the Florida Department of Health. New York does not require a separate state controlled substance registration in addition to DEA registration for licensed practitioners, but requires controlled substance practitioners to register with the New York Bureau of Narcotic Enforcement under the Public Health Law. Each state's processing timeline for its controlled substance registration is independent of DEA processing, meaning a buyer may receive DEA approval but still be waiting on state approval before operations can commence.
The dual registration requirement creates a two-track application process that must be managed in parallel. The buyer should identify every state in which the target practice holds a DEA registration and determine whether that state requires a separate state controlled substance registration. For practices operating in multiple states, the analysis must be repeated for each jurisdiction. The purchase agreement should include representations from the seller confirming that all state controlled substance registrations are current, that there are no outstanding compliance violations under any state registration, and that the seller will cooperate in notifying each state's controlled substance authority of the change of ownership and the buyer's pending registration applications.
Asset Deal vs. Stock Deal Distinction for DEA: Practitioner Change of Address and Entity Continuity
The distinction between an asset acquisition and a stock acquisition has significant implications for DEA registration requirements, though the outcome is less intuitive than in other areas of law. In a stock acquisition, the legal entity that holds the DEA registration remains in existence and continues to be the contracting party. The DEA registration is issued to that entity, and the entity's ownership structure changes without affecting the registration's validity. This is the one context in which a DEA registration survives a transaction without a new application, because the registrant has not changed: the same legal entity remains the holder of the same registration.
However, a stock acquisition that results in a change of the entity's principal officers, DEA-identified responsible parties, or designated registered agent may trigger a notification or modification obligation under DEA regulations. The DEA requires registrants to notify the applicable Diversion Field Office within 30 days of any change in the identity, business address, or principal officers of a registered entity. A buyer who acquires 100% of the equity in a registered practice entity and installs new management must report that change and may be required to submit a modification to the registration identifying the new responsible parties. Failure to report material changes to the DEA is a regulatory violation that can result in registration modification proceedings or referral to the DEA's diversion investigators.
In an asset acquisition, the selling entity retains its DEA registration and the buyer acquires the practice assets without inheriting the seller's registration. The buyer must apply for its own registration as described above. The seller's registration must be surrendered to the DEA at closing or as soon as the seller ceases controlled substance activities at the registered location, because maintaining an active registration for a location where no authorized controlled substance activities are being conducted creates unnecessary regulatory exposure for the seller and may create confusion in DEA records if the buyer's new registration covers the same address.
A practitioner change of address, distinct from a full registration transfer, is relevant when an individual practitioner changes the registered location for their personal DEA registration. If a selling veterinarian or dentist plans to continue practicing at a different location after closing, they must notify the DEA of their new address and update their registration accordingly. This is a separate process from the buyer's new registration application and must be addressed in the transition plan to ensure that the seller's registration does not continue to show the acquired practice address in DEA records after the buyer's registration is issued for that same address, which could create conflicting records.
State Veterinary Board Change of Ownership Notification: California BPC 4853, NY Article 135, Texas Occupations Code Chapter 801
State veterinary licensing boards regulate both individual practitioners and, in many states, the facilities at which veterinary medicine is practiced. A change of ownership in a veterinary practice triggers notification and, in some states, formal re-licensure obligations that run independently of DEA registration requirements. These obligations must be identified and addressed in the transaction timeline, and failure to comply can result in the practice operating without proper state authorization after closing, exposing both the buyer and any licensed practitioners employed by the buyer to disciplinary action.
California Business and Professions Code Section 4853 requires that a veterinary premises permit be obtained by any person or entity operating a veterinary facility in California. The permit is issued to the premises operator, not to an individual practitioner, and a change of ownership requires a new premises permit application. The California Veterinary Medical Board's change of ownership process requires the new owner to submit a premises permit application, pay the applicable fee, and designate a California-licensed veterinarian as the responsible practitioner for the facility. The Board conducts a review of the application and may conduct an inspection of the premises before issuing the new permit. Processing times vary by Board workload but typically range from 30 to 60 days for a complete application.
New York Education Law Article 135 governs the practice of veterinary medicine in New York. New York does not issue separate facility permits for veterinary practices in the same manner as California, but the corporate practice of veterinary medicine in New York is restricted to entities organized under the Business Corporation Law as professional service corporations whose shareholders are all licensed veterinarians. An acquiring entity that does not satisfy New York's professional corporation ownership requirements cannot lawfully operate a New York veterinary practice, regardless of whether it has obtained DEA registration and other required authorizations. This restriction is the central structural issue in New York veterinary and dental acquisitions and must be resolved through a compliant entity structure before the transaction closes.
Texas Occupations Code Chapter 801 governs the practice of veterinary medicine in Texas. The Texas State Board of Veterinary Medical Examiners issues licenses to individual veterinarians rather than to facilities, but it requires that veterinary facilities operating in Texas be under the supervision of a licensed Texas veterinarian who is responsible for the professional conduct of the practice. A change of ownership must be reported to the Board, and the new owner must designate a Texas-licensed veterinarian as the responsible supervisor. The Texas Board does not currently require a separate facility permit in addition to the individual practitioner license, but the designation of the responsible veterinarian must be current and accurate in Board records at all times. A buyer who acquires a Texas veterinary practice without immediately confirming the designation of a responsible licensed veterinarian in Board records is operating in a compliance gap.
State Dental Board Approval: California Dental Practice Act Section 1700, NY Education Law 6605, and Facility Permit Transfer
State dental licensing boards impose ownership, facility, and practitioner requirements that apply independently of DEA registration obligations. The corporate practice of dentistry doctrine, which restricts ownership of dental practices to licensed dentists or compliant professional entities in most states, is the foundational structural issue in any dental practice acquisition. It determines who can legally own the practice, how the acquiring entity must be structured, and what approvals are required from the dental board before the transaction can close and operations can commence.
California's Dental Practice Act, codified in California Business and Professions Code Section 1700 et seq., requires that dental practices in California be owned and operated by licensed dentists or by dental corporations organized under the Moscone-Knox Professional Corporation Act, with ownership restricted to licensed dentists. Non-dentist investors, private equity structures, and management companies cannot directly own or operate California dental practices. Instead, acquisitions in California typically use a management services organization structure in which a non-dentist entity provides administrative, operational, and management services to a dentist-owned professional corporation under a long-term management services agreement. The Dental Board of California reviews the corporate structure of dental organizations operating in California and has taken enforcement action against arrangements it determines constitute unlawful corporate practice.
New York Education Law Section 6605 establishes the corporate practice of dentistry prohibition in New York, requiring that dental practice be conducted only by individual licensed dentists or by professional service corporations organized under the Business Corporation Law with dentist ownership requirements. New York's approach is among the most restrictive in the country, and DSO structures that use management agreements to work around ownership restrictions face significant scrutiny from the New York State Education Department's Office of the Professions. A buyer acquiring a New York dental practice must confirm that the entity structure complies with New York law before closing and that any management agreement with a non-dentist entity does not give the MSO control over clinical decisions, patient selection, or fee-setting in a manner the Department would characterize as unlawful corporate practice.
Dental facility permits are required in most states and are issued to the operating entity or individual at the specific facility address. California requires a permit from the Dental Board for each facility at which dental services are provided. A change of ownership requires a new permit application, and the Board will not transfer an existing permit to a new owner. Texas requires a permit from the Texas State Board of Dental Examiners for each dental facility, and the permit must be obtained before the facility commences operations under new ownership. The purchase agreement should include a closing condition requiring that all material dental board approvals and facility permits in the buyer's name be obtained before closing, or should specify an alternative structure such as a delayed closing of specific permit-dependent operations if particular approvals are expected to lag the main closing date.
Facility Permit vs. Practitioner License: Two-Layer Analysis, Mobile Clinics, and Satellite Offices
Veterinary and dental regulatory frameworks impose two distinct layers of licensing requirements in most states: one layer governing the individual practitioner who provides professional services, and a second layer governing the facility at which those services are provided. Both layers must be satisfied independently. A licensed practitioner operating at an unlicensed facility violates the facility permit requirement regardless of their individual licensure status. A compliant facility operating without a licensed practitioner in the required supervisory role violates the practitioner requirement regardless of the facility's permit status. Diligence must confirm compliance with both layers at every location included in the acquisition.
The distinction between a facility permit and a practitioner license has particular relevance in the change of ownership context. In an asset acquisition, the buyer typically must obtain both a new facility permit in its name and confirm that the practitioner or practitioners who will be employed by the buyer hold individual licenses in the applicable state. The seller's facility permit cannot be assigned to the buyer, and the seller's individual practitioner license does not extend to the buyer's employed practitioners. The transaction timeline must account for both application processes, which may have different processing times and different state agency contacts.
Mobile veterinary clinics and dental mobile units present a specific regulatory challenge because the facility permit requirement is designed around fixed premises. States address mobile practice differently. Some states require a separate mobile clinic permit in addition to the practitioner license, with the permit tied to the primary business address from which the mobile unit operates. Other states regulate mobile practice through the practitioner's license conditions rather than through a separate facility permit. California, Texas, and Florida each have specific regulations governing mobile veterinary practice, and mobile dental practice is regulated under similar but not identical frameworks in each state. An acquirer of a mobile practice must confirm the specific permit and license requirements for each state in which the mobile unit operates, because the unit may cross state lines and require compliance in multiple jurisdictions.
Satellite offices present a related but distinct issue. A practice that operates a primary location and one or more satellite offices typically needs a separate facility permit for each satellite location and must designate a responsible licensed practitioner for each location at which services are provided. The satellite offices may also require separate DEA registrations if controlled substances are stored or dispensed at those locations. An acquirer who does not conduct location-by-location diligence may discover post-closing that satellite offices are operating without proper facility permits, that DEA registrations at satellite locations were held personally by the selling practitioners and have not been transferred, or that state board records show the acquired practice operating at locations not reflected in the seller's representations. The purchase agreement should include representations covering each location separately and should attach schedules identifying every address at which the practice operates.
DEA and State Licensing Timelines Must Be Built Into the Transaction Structure Before Signing
A buyer who signs a purchase agreement without confirming DEA application processing times and state board approval timelines is building a closing schedule on an unknown variable. Counsel experienced in veterinary and dental M&A identifies these timelines at the letter of intent stage and structures the deal to account for them.
DEA Certificate of Registration: Practitioner vs. Researcher vs. Practitioner-Dispenser Distinctions
The DEA issues different types of registrations depending on the applicant's authorized activities, and the type of registration determines what the registrant is permitted to do with controlled substances. In veterinary and dental practice acquisitions, the relevant registration types are the practitioner registration, which authorizes dispensing, administering, and prescribing controlled substances in the course of professional practice, and the practitioner-dispenser registration, which applies in states where veterinary or dental practitioners fill and dispense controlled substance prescriptions directly to patients from on-site stock rather than routing all prescriptions through licensed pharmacies.
A practitioner registration authorizes a licensed veterinarian or dentist to administer controlled substances directly to patients in the course of treating them and to write prescriptions for controlled substances that patients fill at licensed pharmacies. The practitioner registration does not authorize the registrant to act as a pharmacy and fill prescriptions for third-party patients who are not under the registrant's care. Veterinary practices that maintain an in-clinic pharmacy and fill controlled substance prescriptions for patients departing the clinic with medications are operating under a practitioner-dispenser model that must be reflected in their DEA registration type and in their compliance with state pharmacy laws.
Researcher registrations are issued to entities conducting DEA-approved research on controlled substances and are distinct from practitioner registrations. A veterinary school or dental research institution that holds a researcher registration cannot use that registration for clinical practice activities. An acquiring entity that assumes it can use an inherited researcher registration for clinical dispensing activities is making a material compliance error that constitutes an unregistered controlled substance activity. Diligence should identify every DEA registration held by the target, confirm the registration type for each, and verify that the activities conducted under each registration match its authorized scope.
The buyer's Form 224 application must specify the registration type that matches its intended controlled substance activities at the acquired location. A buyer who intends to operate an in-clinic dispensing operation must apply for the appropriate registration type that covers dispensing activities, not just administration. A buyer who intends to refer all prescriptions to outside pharmacies needs only a standard practitioner registration. Applying for the wrong registration type will result in either under-authorization (restricting activities the buyer intended to conduct) or over-authorization (requiring compliance with dispensing-specific requirements the buyer did not anticipate). The application type should be confirmed with DEA counsel before submission.
Drug Inventory Reconciliation: Form 41 Destruction, Form 222 Ordering, and Schedule II Controls
The controlled substance inventory held at the acquired practice location must be accounted for precisely at closing. Federal law and DEA regulations require registrants to maintain complete and accurate records of all controlled substances received, dispensed, administered, and destroyed. A change of ownership that results in a new DEA registrant operating at the location requires a formal inventory and transfer process for the controlled substance stock, because the new registrant's records begin at the point they take possession and must reflect an accurate opening inventory.
In an asset acquisition where the seller's DEA registration does not transfer to the buyer, the controlled substance inventory cannot simply be handed over to the buyer as part of the general asset transfer at closing. The seller remains the registrant for the inventory until the DEA registration is surrendered, and the buyer cannot lawfully possess the inventory as a registrant until its own registration is approved. The practical solutions involve either the seller retaining physical custody of the controlled substance inventory under its registration until the buyer's registration is approved, or the seller destroying the inventory before closing using the DEA's Form 41 disposal process and the buyer ordering fresh stock under its own registration once approved.
DEA Form 41, the Registrant Record of Controlled Substances Destroyed, is used to document the destruction of controlled substances in a manner that complies with DEA regulations. Destruction must be witnessed by two authorized individuals and must result in the substances being rendered non-retrievable. Certain destruction methods require DEA authorization in advance, while others can be carried out by the registrant using DEA-approved on-site destruction kits. The completed Form 41 must be retained for two years in the registrant's records. If the seller elects to destroy the controlled substance inventory before closing rather than maintaining custody through the transition period, the Form 41 documentation must be completed accurately and retained, and the destruction must occur before the seller's registration is surrendered.
Schedule II controlled substances require special handling that goes beyond the general controlled substance recordkeeping requirements. DEA Form 222 is the official order form required for all purchases of Schedule II substances, and it must be used by the new registrant to place its first and all subsequent Schedule II orders once its registration is approved. A buyer who attempts to order Schedule II substances before its DEA registration is approved, or who attempts to use the seller's Form 222 authority to place orders on behalf of the new practice entity, is engaging in an unauthorized Schedule II transaction. The Form 222 ordering process under the Controlled Substance Ordering System requires the ordering registrant to be identified, and orders placed under a registration that has been surrendered or that does not belong to the ordering entity are invalid. The buyer's DEA registration approval and its establishment of a CSOS account for electronic ordering should be on the post-closing checklist as immediate Day 1 items.
State-Specific Timing: Application Processing 30 Days in California and Texas to 90-Plus Days in New York
The most operationally significant variable in any veterinary or dental practice acquisition involving controlled substances is the processing time for state licensing applications. Processing times vary by state, by licensing board workload, by the complexity of the applicant's background, and by whether the application is submitted with all required materials or must be completed in response to a deficiency notice. Counsel must research current processing times for each applicable state board before the letter of intent is executed, because a processing delay of 30 to 60 days beyond the anticipated closing date is a material transaction risk that must be addressed in the deal structure.
California's licensing boards generally process complete applications within 30 to 60 days for veterinary and dental facility permits when no disciplinary history or complex ownership structure issues are present. The California Veterinary Medical Board and the Dental Board of California have online application portals that allow applicants to track status, and Board staff can be contacted to confirm receipt and completeness of an application. Applications that require Board member review due to corporate structure questions or that involve pending disciplinary matters at other licensing boards may take considerably longer. California's Department of Justice, Bureau of Cannabis Control and Narcotic Enforcement, which processes state controlled substance registrations, generally aligns its processing timeline with DEA processing, though independent delays at DOJ can extend the timeline by several weeks.
Texas processes veterinary and dental licensing applications within 30 to 45 days in most cases, and the Texas State Board of Veterinary Medical Examiners and the Texas State Board of Dental Examiners have both made efforts to improve processing efficiency in recent years. Texas's controlled substance registration through the Department of Public Safety adds a parallel track with a similar processing timeline. The Texas State Board of Dental Examiners's facility permit process is relatively straightforward for applicants who have confirmed compliance with all building code and equipment requirements before submitting the application, but inspections required for new facility permits can add time if the Board's inspection schedule is backed up.
New York's Office of the Professions processes dental and veterinary professional license applications and changes of registration for professional service corporations on a timeline that frequently extends to 90 days or more, particularly for applications involving new professional service corporation registrations or changes to existing corporate structures. The Office of the Professions's review of corporate ownership structures for dental and veterinary professional service corporations is thorough and can extend to 120 days or beyond when the ownership structure raises questions. Applications involving DSO or MSO structures that the Office views as potentially implicating the corporate practice prohibition receive the most intensive review and the longest processing times. New York transactions must be planned with this extended timeline in mind, and the purchase agreement's closing conditions and termination rights must reflect the possibility that New York approvals will not be obtained within the standard transaction timeline.
Interim Arrangements: Locum Tenens, Supervising Veterinarian or Dentist of Record During the Registration Gap
When a DEA registration gap or state license processing delay prevents the buyer from operating the full scope of the acquired practice immediately after closing, an interim arrangement must bridge the gap without creating compliance exposure. The two most common interim structures are a locum tenens arrangement, in which a licensed and registered practitioner provides services using their own individual registration while the buyer's registration is pending, and a transition services arrangement, in which the seller continues to hold its registration and operates certain controlled substance activities under a defined management structure for a limited period after closing.
A locum tenens practitioner serving as the supervising veterinarian or dentist of record during a post-closing gap must hold a valid DEA registration for the applicable location, a current state professional license, and, where required, a state controlled substance registration. The locum's DEA registration number must appear on all controlled substance records for activities they personally supervise during the locum period. The locum cannot use the buyer's DEA registration number because the buyer's registration has not yet been issued, and using a registration number that does not match the actual registrant is a federal controlled substance violation. Transition services agreements that structure a locum arrangement must confirm these registration requirements and should include representations from the locum regarding their current and active registration status.
The selling practitioner, if they agree to remain employed or engaged by the buyer in a post-closing transition role, can serve as the practitioner of record under their individual DEA registration for a defined period while the buyer's registration is processed. This arrangement is common in veterinary practice acquisitions where the selling veterinarian remains engaged as a clinical employee for six to twelve months post-closing. The seller's DEA registration must remain active throughout the transition period, which means the seller cannot surrender their registration at closing even though the practice assets have been transferred to the buyer. The transition services agreement should address the DEA registration status explicitly, confirm that the seller will maintain the registration in good standing throughout the transition period, and specify the process for surrendering the registration once the buyer's registration is approved.
The DEA has expressed concern about arrangements in which a registered practitioner serves as a nominal practitioner of record while an unregistered entity actually controls the controlled substance program at a practice. Counsel should review any proposed interim arrangement against the DEA's published guidance on practitioner of record responsibilities and confirm that the licensed practitioner in the arrangement exercises genuine clinical oversight of controlled substance activities rather than serving as a regulatory placeholder. Interim arrangements that the DEA characterizes as a device to circumvent the registration requirement can result in administrative action against both the practitioner and the unregistered entity, and can complicate the buyer's own registration application if the interim conduct is brought to the DEA's attention during the background investigation.
Prescription Drug Monitoring Program Reporting Transition and NABP Interstate Data Sharing
Prescription drug monitoring programs are state-administered databases that collect information about controlled substance prescriptions dispensed by pharmacies and, in states that require direct reporting by dispensing practitioners, by veterinary and dental practices that dispense controlled substances directly to patients. PDMP reporting is a compliance obligation independent of DEA registration and state board licensing, and it must be addressed in the transition plan for any acquisition involving a practice that dispenses or prescribes controlled substances. The buyer must establish its own PDMP account in each state where the practice operates and ensure that prescribing and dispensing records under the buyer's DEA registration are reported under the buyer's account from the first prescription or dispense post-registration.
The National Association of Boards of Pharmacy administers the PMP InterConnect program, which facilitates interstate sharing of PDMP data among participating states. This system allows a prescriber in one state to query another state's PDMP before prescribing to a patient who may have obtained controlled substances in multiple states. When an acquiring entity establishes its PDMP account in each applicable state, it must ensure that the account is linked to the correct DEA registration number and that any prescribers employed by the practice are individually registered in the PDMP system under their own credentials. PDMP registration is typically tied to the prescriber's DEA registration and state license, so a practitioner who holds current DEA registration and state licensure should be able to establish PDMP access relatively quickly once those credentials are confirmed.
The PDMP reporting transition involves both a forward-looking obligation for the buyer's post-closing prescriptions and a historical records consideration for the seller's pre-closing prescriptions. The seller's PDMP records remain in the applicable state databases and are attributable to the seller's DEA registration number. The buyer's PDMP account begins with the buyer's first prescription or dispense under its own registration. There is no transfer of historical PDMP records from the seller's account to the buyer's account, and the buyer should not attempt to access the seller's PDMP account after closing, because PDMP accounts are secured to the specific registered practitioner or entity and unauthorized access constitutes a privacy violation under state law.
Some states require veterinarians and dentists who dispense controlled substances directly from their practices to report dispenses to the PDMP in real time or within defined reporting windows. California, Texas, Florida, and New York all have PDMP reporting requirements that apply to practitioners who dispense controlled substances, though the specific reporting windows and covered substance schedules differ by state. A buyer who acquires a practice with an in-clinic dispensing operation must confirm the applicable PDMP reporting requirements in each state of operation and ensure that its dispensing software or manual reporting system is configured to report under the buyer's DEA registration number from the first dispense after the buyer's registration is approved.
Controlled Substance Compliance Cannot Be Improvised at Closing
PDMP registration, DEA application timing, drug inventory reconciliation, and state board change-of-ownership notifications each require advance planning. Counsel who has structured veterinary and dental practice acquisitions before knows which items to put on the critical path and which closing conditions protect the buyer if approvals are delayed.
Enforcement Risk: DEA Diversion Investigator, State Board Audit, and Closing Condition Drafting
The enforcement consequences of controlled substance compliance failures in the acquisition context are severe and can materially affect the value and operability of the acquired practice. A DEA diversion investigator can initiate an investigation of a veterinary or dental practice based on a compliance complaint, a Pattern of irregular ordering identified through automated monitoring of Form 222 orders, or a referral from a state board or pharmacy investigating an anomaly in PDMP data. An investigation during the ownership transition period is particularly damaging because the records from two different registrants cover a single continuous period of practice operations, and any gap or discrepancy in those records during the transition is potentially attributable to the new owner.
A state board audit of a veterinary or dental practice during or after an acquisition can reveal deficiencies in facility permits, practitioner licenses, or controlled substance handling records that resulted from the transition itself rather than from any pre-existing compliance failure. State boards in California, Texas, and New York conduct periodic audits of licensed facilities and can initiate targeted audits based on complaints or anomalies identified in licensing records. An audit that reveals the practice operated without a valid facility permit between closing and issuance of the new permit, or that controlled substance records show a gap in chain of custody during the transition, can result in a citation, a fine, or a formal disciplinary proceeding against the new owner's license.
The purchase agreement's closing conditions must reflect the DEA and state licensing timeline realities. A condition that simply requires the seller to represent that all licenses and permits are in good standing as of closing does not protect the buyer if the buyer's own applications are not yet approved and controlled substance operations cannot lawfully continue under the new ownership immediately after closing. The more protective structure includes a closing condition requiring that the buyer's DEA registration be approved before closing, or alternatively, a closing condition requiring that an acceptable interim arrangement be in place that the parties have confirmed with DEA counsel will allow controlled substance activities to continue lawfully during any post-closing gap.
The seller's representations and warranties regarding controlled substance compliance should cover the full scope of DEA and state board obligations, including the accuracy of all controlled substance records for the three years preceding closing, the absence of any pending DEA investigation or state board disciplinary proceeding, compliance with all PDMP reporting requirements, and the accuracy of the inventory records for all controlled substances on hand at closing. The indemnification for controlled substance compliance failures should extend through any applicable statute of limitations for DEA administrative proceedings and state board disciplinary actions, which in most cases is at least three to five years from the date of the alleged violation. Acquisitions Stars represents buyers and sellers navigating these regulatory layers in veterinary and dental practice transactions, and provides the legal analysis needed to structure closings that do not create compliance exposure on Day 1 under new ownership. Contact us at 248-266-2790 or through the form below.
Frequently Asked Questions
How far in advance should a buyer submit a DEA Form 224 application before closing a veterinary or dental practice acquisition?
The DEA recommends submitting a new Form 224 application at least 30 days before the applicant intends to handle controlled substances at the registered location. In practice, counsel should target 60 to 90 days before the anticipated closing date for several reasons. The DEA processes applications through a background investigation that can extend beyond the stated 30-day window if the applicant's history requires additional review, if the application is incomplete, or if the DEA's workload is elevated. For a buyer acquiring a practice where controlled substance dispensing is central to clinical operations, a gap between closing and registration creates immediate compliance exposure and potential patient care disruption. Submitting the application in parallel with the letter of intent rather than waiting for a signed purchase agreement gives the buyer the widest possible buffer. The application requires identification of the specific registered location, the business structure of the registrant, and the type of controlled substances to be handled, all of which are typically known by the LOI stage.
Can a dental or veterinary practice continue dispensing controlled substances during the gap between closing and DEA registration approval?
There is no lawful mechanism for a buyer who does not yet hold a DEA registration to dispense, administer, or prescribe controlled substances at the acquired practice location. The Controlled Substances Act is clear that a registration is required before any such activity occurs. The practical solutions to the gap problem fall into two categories. First, a licensed practitioner who already holds their own DEA registration, such as the selling veterinarian or dentist if they remain employed post-closing, can continue personally authorized controlled substance activities using their individual registration. Second, the parties can structure a delayed closing of the controlled substance inventory until the buyer's registration is approved, continuing to operate the practice under the seller's registration during a transition services period with clearly defined custody and reconciliation obligations. Neither approach is without risk, and both require careful documentation of how the controlled substances are being managed during the interim period. Counsel should confirm the DEA regional field office's current processing times and build the closing schedule accordingly.
Is locum tenens coverage a viable solution for controlled substance dispensing during the post-closing DEA registration gap in a veterinary practice?
A locum tenens veterinarian who holds their own individual DEA registration and is authorized to practice in the applicable state can lawfully handle controlled substances within the scope of their own registration during a post-closing gap. However, there are meaningful limitations. The locum's DEA registration authorizes them personally, not the practice or the acquiring entity. Controlled substance records during the locum period must reflect the locum's DEA registration number, creating a documentation split in the practice's controlled substance logs that must be addressed in the post-registration audit. The DEA has issued guidance indicating that a locum arrangement must reflect genuine clinical responsibility rather than a device to allow an unregistered entity to effectively control controlled substance dispensing through a registered individual. The buyer should obtain written confirmation from DEA counsel that the specific locum arrangement is structured to comply with this guidance, and should document the locum's independent clinical authority during the coverage period in the transition services agreement.
Are there expedited licensing options available through state veterinary or dental boards when a buyer faces a timing gap before closing?
Several states have created expedited or provisional licensing pathways that can shorten the standard processing window for veterinary and dental license applications. California's Veterinary Medical Board offers an expedited process for applicants with clean disciplinary histories who submit complete applications, though processing still takes 30 to 45 days in most cases. Texas and Florida offer provisional authorization letters that allow practice under supervision while the full license application is reviewed. New York's Office of the Professions does not offer a formal expedite program but will in some cases respond to attorney-submitted requests for priority review where a legitimate business need is documented. The practical approach is to submit a complete application immediately upon letter of intent execution, identify the specific processing bottlenecks the state board is experiencing at the time of application, and coordinate directly with the board's licensing division to confirm whether any priority processing mechanism is available. Counsel with established relationships with the relevant licensing boards can often obtain status updates and address deficiencies faster than an applicant acting alone.
How does a mobile veterinary practice acquisition affect DEA registration and state license transfer obligations?
A mobile veterinary practice presents a distinct registration challenge because the DEA requires a separate registration for each location where controlled substances are stored, and a mobile operation may not have a fixed address that satisfies the DEA's location requirements. The DEA's mobile veterinarian registration policy permits practitioners to obtain a single registration for their primary business address and then apply for an exception covering mobile or field operations conducted from that registered location, provided controlled substances are returned to the registered location when not in active use and are not stored overnight in the vehicle. A buyer acquiring a mobile veterinary practice must confirm whether the seller operated under this exception, whether the documentation practices complied with DEA requirements, and whether the same exception will be available to the buyer under their own registration. State veterinary board licensing for mobile practices requires a separate analysis under each state's mobile or itinerant practice rules, which vary significantly. Texas, California, and Florida each have specific mobile practice permit requirements that may require separate facility approval in addition to the practitioner license.
Does a dental facility permit transfer to the buyer in an asset acquisition, or must the buyer obtain a new permit?
Dental facility permits in most states are issued to the entity or individual operating the facility and are not transferable to a new owner in an asset acquisition. California's Dental Practice Act requires a new dental office permit application when there is a change of ownership, and the Dental Board of California will not accept assignment of an existing permit. New York requires notification to the Office of the Professions within 30 days of any change in ownership of a dental practice, and the new owner must satisfy the professional corporation ownership requirements under the Education Law before practicing at the facility. Texas requires a new facility permit through the Texas State Board of Dental Examiners whenever a facility changes ownership. The practical consequence is that a buyer in an asset acquisition must submit a facility permit application as early as possible in the transaction timeline and must not assume that the seller's existing permit will cover operations after closing. The purchase agreement should include a closing condition requiring delivery of all material state and local facility permits and licenses in the buyer's name before closing occurs.
Can a buyer submit a DEA Form 224 application for a veterinary or dental practice before the acquisition closes?
A buyer can submit a Form 224 application before the acquisition closes, identifying the target practice location as the proposed registered address. The DEA does not require that the applicant own or have possessory rights to the location at the time of application; the registration is issued to the applicant for activities that will occur at the specified address. However, the application must accurately represent the applicant's intended use of controlled substances and must not misrepresent that the applicant is already conducting controlled substance activities at the location before the acquisition closes and before the registration is approved. Many practitioners in acquisition contexts submit the Form 224 identifying the proposed opening date or acquisition date as the intended commencement date, which avoids any representation that activities are ongoing before authorization exists. The DEA regional office can be contacted directly to confirm this approach is acceptable in the specific jurisdiction, as regional offices have some discretion in processing applications from applicants who are acquiring an existing practice.
What remedies are available if the DEA registration transfer or state license transfer fails to complete before closing?
When a DEA registration or state license transfer cannot be completed before the scheduled closing date, the parties have several structural options for managing the failure. The most common remedy is a delayed closing conditioned on receipt of the required registrations and licenses, with a drop-dead date after which either party may terminate the purchase agreement. Alternatively, the parties can close the non-controlled-substance portions of the acquisition on schedule and defer the transfer of the controlled substance inventory and associated operations to a second closing that occurs when the DEA registration is approved, with the seller retaining legal custody of the inventory under a management agreement during the interim period. A third option is a management agreement structure under which the buyer manages the practice operations post-closing under the seller's existing licenses, with an assignment or re-licensing occurring once all registrations are in place. Each of these structures carries specific legal risks and requires coordination with the DEA and state licensing boards to confirm that the interim arrangement does not itself constitute a violation of the applicable licensing requirements.
Related Resources
Veterinary and Dental DSO M&A: Legal Guide
The complete legal framework for M&A transactions involving veterinary practices and dental service organizations, from diligence through closing.
RelatedDSO and MSO Corporate Practice of Medicine Structure in M&A
How dental service organization and management services organization structures are built to comply with corporate practice of medicine prohibitions in M&A transactions, and what buyers and sellers must confirm before closing.
RelatedClinical Integration and Associate Employment Agreement in M&A
The legal framework for associate employment agreements, non-compete clauses, and clinical integration covenants in veterinary and dental practice acquisitions, including state-specific enforceability analysis.
DEA registration and state professional licensing are not due diligence checkboxes. They are operational prerequisites that determine whether the buyer can conduct the core revenue-generating activities of the acquired practice from the moment of closing. A veterinary practice that cannot administer sedation or pain management medications on Day 1 because the buyer's DEA registration has not been approved is a practice that cannot operate as acquired. A dental practice that cannot dispense or prescribe controlled substances during the registration gap is a practice with a service limitation that the purchase price did not contemplate.
The resolution is not complex: submit the Form 224 and all state licensing applications as early as possible, build the closing timeline around confirmed processing windows, and draft the purchase agreement's closing conditions to protect the buyer if approvals are delayed beyond the scheduled closing date. Acquisition Stars advises buyers and sellers in veterinary and dental practice transactions on the full scope of controlled substance and licensing compliance requirements, and structures transactions to ensure that regulatory readiness is confirmed before, not after, the parties execute closing documents. Contact us at 248-266-2790 or through the form below to discuss your transaction.
Written by Alex Lubyansky, Managing Partner, Acquisition Stars. Alex advises on M&A transactions in regulated industries including veterinary, dental, and healthcare services, with a focus on controlled substance compliance, licensing transitions, and corporate practice of medicine structures.